Henry Stone, Clarence Reid and Willie Clark (in a comment to SongFacts on an interview conducted with Finch in 2010) introduced Finch to Harry Wayne Casey, three years his senior. His high school attendance suffered as he spent every free moment at TK Records and unbeknownst to his mother, he dropped out of high school his sophomore year and shortly thereafter was hired as a part-time recording engineer for the label. A schoolmate introduced him to the singer-songwriter Clarence Reid from TK Records. įinch became interested in audio recording techniques while working at an Opa Locka, Florida electronics and record store. He joined several country bands before joining the band Ball & Chain. In his early teens, Finch got his first electric bass guitar and began to learn country music bass lines. His musical tastes grew to include soul and country music. His favorite group growing up was The Beatles. At five years old and the second youngest of five children, Finch's father died unexpectedly leaving his mother to raise Finch and his four siblings alone. 1 Billboard Hot 100 hits.īorn in Indianapolis, Indiana, Finch's family moved to Hialeah, Florida, when he was an infant. Along with Harry Wayne Casey, he co-wrote the majority of the KC and the Sunshine Band music catalog, to include five No. He is best known as the co-founder, producer and former bass guitar player of KC and the Sunshine Band. I’m eager to help our customers transform their businesses so they can achieve their collective goal of bringing life-saving therapies to market as quickly and efficiently as possible.”ġ.“Unlocking R&D productivity: Measuring the return from pharmaceutical innovation.” Deloitte LLC, 2018.Richard Raymond Finch (born January 23, 1954) is an American songwriter, producer, and arranger. “It’s exciting to work with such a talented team, which can leverage our platforms and AI-enabled solutions to advance drug and device research. “Clarivate is widely recognized as a leader in information and analytics for the life sciences industry,” states Finch. Most recently, Finch was Senior Vice President of Industry Solutions for Outcome Health, a PE-backed start-up, where he led sales efforts with life sciences and healthcare customers for the company’s point-of-care solutions. While at Accenture, he also served as North America Consulting Head for the cross-industry Product Group that included life sciences, consumer goods and retail clients. Prior to Clarivate, Finch held senior executive roles at several leading and innovative companies, including Accenture, where he was a Managing Director and Global Head of all commercial consulting engagements for a top 5 global pharmaceutical company. Rick brings significant relevant experience in scaling a consulting business and partnering with clients to accelerate innovation.” “Our goal is to help customers make data-driven decisions that fuel faster, more efficient development, optimize the value of their assets and improve operational performance. “Drug and device manufacturers are under unprecedented pressure to bring novel treatments to market in an environment that is riddled with risk and uncertainty,” said Mukhtar Ahmed, President, Life Sciences at Clarivate Analytics.

Finch and his team of consultants will apply deep industry and functional expertise, combined with proprietary methodologies, artificial intelligence (AI) and machine learning platforms, to transform clients’ businesses and improve decision-making across the development and commercialization spectrum. With R&D and commercialization costs exceeding $2 billion to bring just one asset to market and average sales per asset declining by 50 percent since 2010, 1 drug and device companies require more effective and efficient solutions across the entire development lifecycle. Finch’s appointment will further expand the company’s consulting business, which delivers insights, recommendations and solutions focused on discovery and clinical development regulatory strategy and pharmacovigilance product portfolio, business development and licensing strategies digital health and technology and data science.įinch joins Clarivate at a time when the industry continues to struggle to identify novel solutions and breakthrough therapies. Finch as the Global Head of Life Sciences Consulting Services. Clarivate Analytics plc (NYSE:CCC CCC.WS), a global leader in providing trusted insights and analytics to accelerate the pace of innovation, announced today the appointment of Richard C.

Richard c finch